Topic: Rick Doblin

The US Food and Drug Administration has approved its first clinical study of Ecstasy since the drug was criminalised in 1985. "MDMA really helps reduce the fear response to a perceived emotional threat," says Rick Doblin, President of the Multidisciplinary Association for ...

Can the Peace Drug Help Clean Up the War Mess?

Michael Bledsoe's story begins like that of many other Iraqi war veterans. In 2007, he was chasing insurgents through Anbar province when a roadside bomb exploded, breaking Bledsoe's back and both his feet. A former Army Ranger working as a ...
DEA rejects UMass professor's bid to grow marijuana for medical researchThe Drug Enforcement Administration has rejected a petition by a University of Massachusetts-Amherst professor to let him grow marijuana for medical research.The DEA's Jan. 7 ruling said Lyle Craker ...

Keeping the psychedelic dream alive

Turn on, tune in, drop out, was the mantra of the 60s guru Timothy Leary, who ran experiments on using LSD at Harvard. Millions of America's youth listened - including the teenage Rick Doblin. But Leary's work ran into serious criticism ...
Turn on, tune in, drop out, was the mantra of the 60s guru Timothy Leary, who ran experiments on using LSD at Harvard. Millions of America's youth listened - including the teenage Rick Doblin. But Leary's work ran into serious criticism ...

Interview: The psychedelic pioneer

Turn on, tune in, drop out, was the mantra of the 60s guru Timothy Leary, who ran experiments on using LSD at Harvard. Millions of America's youth listened - including the teenage Rick Doblin. But Leary's work ran into serious criticism ...

Interview: The drugs are alright

Turn on, tune in, drop out, was the mantra of the 60s guru Timothy Leary, who ran experiments on using LSD at Harvard. Millions of America's youth listened - including the teenage Rick Doblin. But Leary's work ran into serious criticism ...

The acid test

Cycling home from the Sandoz Pharmaceutical Laboratories in 1943, the Swiss biochemist Albert Hofmann found himself on the trip of his life. Five years earlier, in a search for novel therapeutic agents to treat migraines, Hofmann had combined an ergot alkaloid, lysergic ...